bhaskarlive

Sudarshan Pharma Industries to Acquire 9.5% Stake in US-Based MedTherapy Biotech

Mumbai (Maharashtra) [India], September 7: BSE-listedSudarshan Pharma Industries Ltd [BSE Scrip Code: 543828, Trading Symbol: SUDARSHAN, ISIN: INE00TV01023]has announced its first major overseas biotech acquisition. In a disclosure under Regulation